Apolipoproteïna E (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apolipoproteïna E" in Catalan language version.

refsWebsite
Global rank Catalan rank
4th place
7th place
1,626th place
8,169th place
5th place
5th place
43rd place
170th place
4,455th place
1,947th place
120th place
122nd place
2nd place
6th place

doi.org

dx.doi.org

ensembl.org

May2017.archive.ensembl.org

jbc.org

nih.gov

ncbi.nlm.nih.gov

  • «Human PubMed Reference:». National Center for Biotechnology Information, U.S. National Library of Medicine.
  • «Mouse PubMed Reference:». National Center for Biotechnology Information, U.S. National Library of Medicine.
  • Singh PP, Singh M, Mastana SS (2002). "Genetic variation of apolipoproteins in North Indians". Hum. Biol. 74 (5): 673–82. doi:10.1353/hub.2002.0057. PMID: 12495081
  • Pericak-Vance, M. A.; Bebout, J. L.; Gaskell, P. C.; Yamaoka, L. H.; Hung, W. Y. «Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage». American Journal of Human Genetics, 48, 6, 6-1991, pàg. 1034–1050. ISSN: 0002-9297. PMC: 1683100. PMID: 2035524.
  • Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C. «Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families». Science (New York, N.Y.), 261, 5123, 13-08-1993, pàg. 921–923. DOI: 10.1126/science.8346443. ISSN: 0036-8075. PMID: 8346443.
  • Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE (1994). "Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease". Nat. Genet. 7 (2): 180–4. doi:10.1038/ng0694-180.PMID: 7920638
  • Mason RP, Shoemaker WJ, Shajenko L, Chambers TE, Herbette LG (1992). "Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol". Neurobiol. Aging 13 (3): 413–9. doi:10.1016/0197-4580(92)90116-F.PMID: 1625771
  • Eckert GP, Kirsch C, Leutz S, Wood WG, Müller WE (September 2003). "Cholesterol modulates amyloid beta-peptide's membrane interactions". Pharmacopsychiatry 36 Suppl 2: S136–43. doi:10.1055/s-2003-43059. PMID: 14574628
  • Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG (June 1998). "Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol". J. Biol. Chem. 273 (26):16576–82. doi:10.1074/jbc.273.26.16576. PMID: 9632729
  • Lepara O, Valjevac A, Alajbegović A, Zaćiragić A, Nakas-Ićindić E (August 2009). "Decreased serum lipids in patients with probable Alzheimer's disease". Bosn J Basic Med Sci 9 (3): 215–20. PMID: 19754476
  • Golomb BA, Evans MA (2008). "Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism". Am J Cardiovasc Drugs 8 (6): 373–418.doi:10.2165/0129784-200808060-00004. PMC 2849981. PMID: 19159124

pubmed.ncbi.nlm.nih.gov

researchgate.net

wikidata.org

worldcat.org